Your institution may have access to this item. Find your institution then sign in to continue.
Title
Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial.
Authors
Mok CC; Tong KH; To CH; Siu YP; Ma KM
Publication
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008, Vol 19, Issue 3, p357